SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD) BWI SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD) creativebharatgroup@gmail.com December 16, 2024 Beijing, China: Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a... Read More Read more about SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
